Table 1 Patient clinical characteristics
Variable | n (%) |
|---|---|
Age (y) | |
Median (range) | 75 (38-100) |
Gender | |
Male | 79 (59) |
Female | 54 (41) |
PS | |
3 | 103 (77) |
4 | 30 (23) |
Concomitant disease associated with worsening PS | |
Yes | 19 (14) |
No | 114 (86) |
Primary site | |
Lung | 51 (38) |
Stomach | 8 (6) |
Esophagus | 8 (6) |
Bladder | 8 (6) |
Breast | 7 (5) |
Colorectum | 7 (5) |
Prostate | 7 (5) |
Liver | 6 (5) |
Other | 31 (23) |
No. of metastatic lesion | |
0-3 | 30 (23) |
≧ 4 | 103 (77) |
Histology | |
Squamous cell carcinoma | 30 (23) |
Adenocarcinoma | 35 (26) |
Small cell carcinoma | 15 (11) |
Hepatocellular carcinoma | 6 (5) |
Transitional cell carcinoma | 6 (5) |
Other | 41 (31) |
No. of irradiated site | |
One site | 117 (88) |
Two sites | 15 (11) |
Three sites | 1 (1) |
Irradiated site (n = 150) | |
Primary tumor | |
Bladder | 7 (5) |
Lung | 7 (5) |
Esophagus | 5 (3) |
Uterus | 3 (2) |
Rectum | 3 (2) |
Others | 9 (6) |
Metastatic tumor | |
Bone | 86 (57) |
Vertebrate | 47 |
Pelvic | 17 |
Rib | 10 |
Femur | 4 |
Others | 8 |
Brain | 18 (12) |
Mediastinum | 5 (3) |
Head and neck | 3 (2) |
Others | 4 (3) |